Search
Sign In
Sign In
Sources
7 Total Sources
FDA Approves Gilead's $4,595 Bixlenvo HIV Pill for 5% Unable to Use One-Tablet Options
Left
33%
Center
50%
Right
17%
All
7
Left
2
Center
3
Right
1
Others
1
CNBC
1d ago
FDA Approves Gilead's Bixlenvo, a Once-Daily HIV Pill for Complex Regimens
FiercePharma
1d ago
Gilead christens Bixlenvo with FDA nod for new HIV treatment combo tablet | Fierce Pharma
Washington Business Journal
1d ago
Gilead wins approval of single-pill HIV treatment Bixlenvo - San Francisco Business Times
Reuters
1d ago
US FDA approves Gilead's once-daily combination pill for HIV treatment | Reuters
investors.gilead.com
1d ago
Gilead Sciences, Inc. - U.S. FDA Approves Gilead's Bixlenvo™, a New Once- Daily Single Tablet Option for Virologically Suppressed Adults With HIV, Including Those on Complex Regimens
Joplin Globe
1d ago
U.S. FDA Approves Gilead's Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults With HIV, Including Those on Complex Regimens | National Business | joplinglobe.com
MarketWatch
1d ago
FDA Approves Gilead Sciences' Bixlenvo for Certain Adults With HIV - MarketWatch